PT - JOURNAL ARTICLE AU - Stange, Madlen AU - Wuerfel, Eva AU - Peter, Jelissa Katharina AU - Seth-Smith, Helena AU - Roloff, Tim AU - Gsponer, Severin AU - Mari, Alfredo AU - Gil, Blanca Cabrera AU - Lebrand, Aitana AU - Wegner, Fanny AU - Heininger, Ulrich AU - Bielicki, Julia AU - Sutter, Sarah Tschudin AU - Stadler, Tanja AU - Leuzinger, Karoline AU - Hirsch, Hans H. AU - Ledergerber, Markus AU - Fuchs, Simon AU - Egli, Adrian TI - SARS-CoV-2 in schools: genome analysis shows that concurrent cases in the second and third wave were often unconnected AID - 10.1101/2022.01.26.22269824 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.26.22269824 4099 - http://medrxiv.org/content/early/2022/01/28/2022.01.26.22269824.short 4100 - http://medrxiv.org/content/early/2022/01/28/2022.01.26.22269824.full AB - Background The risk of SARS-CoV-2 (SCoV2) infection in schools and student households is typically assessed using classical epidemiology whereby transmission is based on time of symptom onset and contact tracing data. Using such methodologies may be imprecise regarding transmission events of different, simultaneous SCoV2 variants spreading with different rates and directions in a given population. We analysed with high resolution the transmission among different communities, social networks, and educational institutions and the extent of outbreaks using whole genome sequencing (WGS).Methods and Findings We combined WGS and contact tracing spanning two pandemic waves from October 2020 to May 2021 in the Canton of Basel-City, Switzerland and performed an in-depth analysis of 235 cases relating to 22 educational institutions. We describe the caseload in educational institutions and the public health measures taken and delineate the WGS-supported outbreak surveillance.During the study period, 1,573 of 24,557 (6.4%) children and 410 of 3,726 (11%) staff members from educational institutions were reported SCoV2 positive. Thereof, WGS data from 83 children, 35 adult staff in 22 educational institutions and their 117 contacts (social network, families) was available and analysed. 353 contextual sequences from residents of the Canton of Basel-City sequenced through surveillance were identified to be related to cases in the educational institutions. In total, we identified 55 clusters and found that coinciding SCoV2-cases in individual educational institutions were mostly introduced from different sources such as social networks or the larger community. More transmission chains started in the community and were brought into the educational institutions than vice versa (31 vs. 13). Adolescents (12-19 years old) had the highest case prevalence over both waves compared to younger children or adults, especially for the emerging Alpha variant.Conclusions Introduction of SCoV2 into schools accounts for most events and reflects transmission closely related to social activity, whereby teenagers and young adults contribute to significant parallel activity. Combining WGS with contact tracing is pivotal to properly inform authorities about SCoV2 infection clusters and transmission directions in educational settings and the effectiveness of enacted public health measures. The gathered data showing more clusters to seed in the community than vice versa as well as few subsequent in-school transmissions indicate that the agilely employed health measures for educational institutions helped to prevent outbreaks among staff and children.The clinical trial accession number is NCT04351503 (clinicaltrials.gov).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was assessed and approved by the local ethical committee (Ethikkommission Nordwest und Zentralschweiz, www.eknz.ch; ID number: 202000769). No signature was required according to the ethical assessment. All data from study participants (pediatric and adult patients) were reported in an anonymous fashion. The clinical trial accession number is NCT04351503 (clinicaltrials.gov)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe SARS-CoV-2 genomes used in this study are accessible at the European Nucleotide Archive (ENA). Accession numbers are listed in Table S2.